ATRC241018C22500
- 5.82
- -0.89-13.26%
AtriCure Newsroom
Here's Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC)
Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?
Radiofrequency Ablation Device Market Global Forecast Report and Company Analysis 2024-2032 Featuring Boston Scientific, Abbott, AtriCure, Medtronic, Stryker, Smith & Nephew, Conmed and Hologic - ResearchAndMarkets.com
AtriCure, Inc. (NASDAQ:ATRC) Soars 29% But It's A Story Of Risk Vs Reward
AtriCure Touts First Case With New FDA-cleared AtriClip Flex-Mini
AtriCure Announces That the First Patient Has Been Treated With the Revolutionary AtriClip FLEX-Mini Device
Is AtriCure (NASDAQ:ATRC) Weighed On By Its Debt Load?
Express News | AtriCure Receives Expanded Indication For AtriClip In Europe For High-Risk Thromboembolism Patients, Validating Its Effectiveness In Reducing Stroke Events During Cardiac Surgery
Express News | AtriCure Receives Expanded Ce-Mark Indication for Atriclip® Devices for the Reduction of Stroke in Patients With Atrial Fibrillation
AtriCure Receives Expanded CE-Mark Indication for AtriClip Devices for the Reduction of Stroke in Patients With Atrial Fibrillation
CCORF Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $49
Atricure's Market Strength and Innovation Justify Buy Rating
US$39.89: That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After Its Latest Results
US$40.89: That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After Its Latest Results
AtriCure Second Quarter 2024 Earnings: EPS Misses Expectations
Oppenheimer Maintains AtriCure(ATRC.US) With Buy Rating, Maintains Target Price $32
Navigating 6 Analyst Ratings For AtriCure
AtriCure Price Target Cut to $53.00/Share From $58.00 by BTIG
AtriCure Is Maintained at Buy by BTIG
Express News | JP Morgan Maintains Overweight on AtriCure, Lowers Price Target to $30